Concerta ER 36 MG tablet 100S
Ended Awarded
- Contract number
- SPE2DB25FU4XQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,675
Award facts
- Contract value 100% obligated
- $22,675.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Concerta ER 36 mg tablets in quantities of 100 units. This firm fixed-price delivery order carries a ceiling value of $22,675.34 and is scheduled for completion by June 27, 2025. The contract was awarded on a competitive, non-set-aside basis and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As the prime contractor on the broader IDC, the company supplies an extensive portfolio of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The Concerta ER tablets being procured under this delivery order support the Defense Health Agency and other federal healthcare systems' medication management needs. AmerisourceBergen's demonstrated capability to compete successfully for federal pharmaceutical contracts reflects its position as a key provider within the DLA Medical Supply Chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FU4XQ?
SPE2DB25FU4XQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 26, 2025.
How much is contract SPE2DB25FU4XQ worth?
The government has obligated $22,675 on SPE2DB25FU4XQ.
Is contract SPE2DB25FU4XQ an order under another contract?
Yes. SPE2DB25FU4XQ is a delivery order under SPE2DB22D2108, an indefinite delivery contract.
Was contract SPE2DB25FU4XQ competed?
The extent of competition for SPE2DB25FU4XQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award